ILLR vs IVF

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 01, 2026

ILLR

43.3
AI Score
VS
IVF Wins

IVF

53.1
AI Score

Investment Advisor Scores

ILLR

43score
Recommendation
HOLD

IVF

53score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric ILLR IVF Winner
Forward P/E 0 0 Tie
PEG Ratio 0 0 Tie
Revenue Growth -5.2% 16.7% IVF
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 43.3/100 53.1/100 IVF
Profit Margin 0.0% -92.3% ILLR
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

ILLR 1M: -74.9% · 3M: -88.3% IVF 1M: -15.3% · 3M: -37.1%

Current Technical Phase

ILLR

Markdown
Sell / avoid

Price below a falling SMA50 (slope -43.2%), weak momentum, RSI 23

RSI (14): 22.5 · Price: $0.25

IVF

Markdown
Sell / avoid

Price below a falling SMA50 (slope -13.7%), weak momentum, RSI 36

RSI (14): 35.6 · Price: $0.86

Fundamentals Snapshot

Metric ILLR IVF
Market Cap — —
Forward P/E 0.0 -0.1
Trailing P/E — 0.0
Revenue (TTM) — —
Revenue Growth -0.1% 0.2%
Gross Margin -3.2% 0.4%
Operating Margin -4.3% -0.6%
EPS -7.81 361.73
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, IVF is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.